Revlimid (lenalidomide) is a brand-name oral capsule that’s prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a first generic ...

(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced Monday the launch of a first generic version of Revlimid (lenalidomide capsules), in 5mg, ...

Doctors prescribe Revlimid (lenalidomide) to treat certain blood cancers, including multiple myeloma, mantle cell lymphoma, and others. The drug is not safe to take while pregnant, and doctors avoid ...

Medicare may cover Revlimid (lenalidomide) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Revlimid is a brand-name drug that doctors ...

Summit, N.J., June 29 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced that the U.S. Food and Drug Administration (FDA) has granted approval for ...

BOSTON, Dec 7 (Reuters) - Celgene Corp said on Monday that a trial of its cancer drug Revlimid showed it reduced the risk of disease progression in newly diagnosed patients with multiple myeloma by 50 ...

Revlimid (lenalidomide) is a brand-name drug that doctors may prescribe to treat certain cancers of the blood. If a person has a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) ...

Low-dose Revlimid delayed transfusion dependency and improved treatment response rates in non-transfusion dependent MDS patients. Revlimid reduced the risk of transfusion dependency by 69.8% compared ...

BOSTON, Dec 1 (Reuters) - Sales of Celgene Corp's cancer drug Revlimid could rise by more than a third if data due to be presented next Monday at the annual meeting of the American Society of ...